ospemifene
Commercial- Indications
- Endometriosis
Company intelligence / Profile preview
Hormos Medical
Turku, Varsinais-Suomi, Finlandbionity.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Hormos Medical developed a platform for tissue-selective modulation of steroid hormone activity, advancing programs for endometriosis and male hypogonadism. The company’s lead asset, fispemifene, showed efficacy in early clinical studies. Its endometriosis program targeted the 17B-HSD1 enzyme and was in preclinical development at the time of asset transfer to Forendo Pharma. The company was acquired by QuatRx Pharmaceuticals; its core team later formed Forendo Pharma to continue development on these programs.
- Therapeutic areas
- Men's HealthEndocrinologyWomen's Health
- Modalities
- Small molecules (notably tissue-specific modulators of steroid hormones)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships identified prior to acquisition; post-acquisition collaborations continued under Forendo Pharma with academic partners.
Beyond the preview
Go deeper on Hormos Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hormos Medical.